V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90067755 | 90052837 | 1.57 | null | null | 2021-06-05 | 2021-07-01 | mEOC TRIAL | N | null | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN | 101224315 |
| 90063156 | 90075169 | null | null | null | 2018-09-09 | 2018-09-23 | mEOC TRIAL | 02 | null | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | 100766100 |
| 30115628 | 30118686 | null | 82.8 | Palliative (P) | null | 2018-06-13 | Zanubrutinib | 02 | N | IFOSFAMIDE + PACLITAXEL | 100833695 |
| 30061743 | 30137660 | 1.68 | 71 | Disease modification (D) | null | 2020-01-21 | Zanubrutinib | null | N | BORTEZOMIB + PANOBINOSTAT | 101552736 |
| 10457185 | 10073680 | 1.65 | 100 | Curative (C) | 2018-11-25 | 2018-11-25 | Zanubrutinib | 02 | N | CARFILZOMIB | 101304930 |
| 70077677 | 70143519 | 1.61 | 71.6 | null | null | 2018-08-21 | Zanubrutinib | 02 | null | CYTARABINE + VINCRISTINE | 101465651 |
| 70080895 | 70143566 | 1.8 | 54.2 | Curative (C) | 2017-10-05 | 2017-10-06 | Zanubrutinib | 02 | null | IFOSFAMIDE + GEMCITABINE + VINORELBINE + RITUXIMAB | 100974111 |
| 70090946 | 70143658 | 1.76 | 92 | null | null | 2019-11-08 | Zanubrutinib | 02 | null | OXALIPLATIN + MDG | 100051884 |
| 70094518 | 70143708 | 1.64 | null | Curative (C) | 2020-10-16 | 2020-10-16 | Zanubrutinib | 02 | null | ETOPOSIDE + IFOSFAMIDE + MTX | 100073146 |
| 70091634 | 70202348 | 1.56 | 55 | Curative (C) | 2019-09-03 | 2019-09-17 | Zanubrutinib | 02 | N | DOXORUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | 101774299 |
| 10299345 | 10071427 | 1.71 | 69.4 | null | 2022-03-23 | 2022-04-08 | Zanubrutinib | 02 | null | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100047422 |
| 10289862 | 10058080 | 1.62 | 60.7 | Neo-adjuvant (N) | 2020-11-20 | 2020-11-23 | Zanubrutinib | 02 | N | AVELUMAB + AXITINIB | 101392804 |
| 70104604 | 70114614 | 1.75 | 84.1 | Curative (C) | 2018-07-28 | 2018-09-07 | Zanubrutinib | 02 | N | CAPECITABINE + GEMCITABINE | 100448790 |
| 70097728 | 70114479 | null | 68 | 03 | 2019-05-31 | 2019-06-02 | Zanubrutinib | 02 | N | REGORAFENIB | 101051100 |
| 30138355 | 30140815 | 1.71 | 49 | Neo-adjuvant (N) | 2017-08-20 | 2017-09-03 | Zanubrutinib | 02 | N | CISPLATIN | 100951576 |
| 70096592 | 70114441 | null | 63 | Palliative (P) | 2016-05-19 | 2016-06-10 | Zanubrutinib | 02 | null | PMITCEBO-R | 101293892 |
| 70080605 | 70114169 | 1.8 | 53.4 | Curative (C) | 2016-02-13 | 2016-11-24 | Zanubrutinib | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100446272 |
| 30134879 | 30137487 | 1.87 | 69.8 | Palliative (P) | null | 2019-12-19 | Zanubrutinib | 02 | N | CISPLATIN | 100376182 |
| 60109317 | 60042912 | null | 92.2 | null | null | 2019-09-25 | ZICE TRIAL | null | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 101740027 |
| 60109025 | 60042763 | 1.66 | 58.9 | null | null | 2017-09-21 | ZICE TRIAL | 02 | null | AZACITIDINE | 100512787 |
| 70103923 | 70161979 | 1.8 | 94.2 | Adjuvant (A) | 2021-02-02 | 2021-02-02 | Z-Dex | N | null | IDARUBICIN | 100746045 |
| 70104214 | 70194752 | 0 | 67 | 03 | 2018-01-21 | 2018-01-27 | Z-Dex | 02 | N | IDARUBICIN | 101740093 |
| 70104652 | 70112224 | 0 | 88.7 | Curative (C) | 2019-08-31 | 2019-11-03 | Z-Dex | 02 | N | IDARUBICIN | 101076908 |
| 70104492 | 70112165 | 1.66 | 82.8 | Disease modification (D) | 2016-04-09 | 2016-04-22 | Z-Dex | 2 | null | IDARUBICIN | 100503127 |
| 70103619 | 70069900 | null | null | Palliative (P) | 2019-04-23 | 2019-04-24 | Z-Dex | N | N | IDARUBICIN | 101627591 |
| 70081462 | 70069315 | 1.8 | 14 | 03 | 2018-12-11 | 2018-12-12 | Z-Dex | 02 | N | IVE-R | 100198269 |
| 70102918 | 70141703 | 1.81 | null | 03 | 2020-01-29 | 2020-02-06 | Z-Dex | 01 | N | IDARUBICIN | 101250042 |
| 70104501 | 70112169 | 1.69 | 64.4 | null | 2019-07-19 | 2019-08-05 | Z-Dex | null | null | IDARUBICIN | 100129321 |
| 70103225 | 70141801 | 1.7 | 54.2 | Curative (C) | null | 2017-10-19 | Z-Dex | 01 | N | IDARUBICIN | 100833285 |
| 70103819 | 70141948 | 1.77 | 80 | null | 2021-07-11 | 2021-07-11 | Z-Dex | 02 | null | IDARUBICIN | 101675022 |
| 70103818 | 70161957 | 0 | 85.2 | null | 2016-10-13 | 2017-02-15 | Z-Dex | null | null | IDARUBICIN | 101508765 |
| 40140076 | 40124380 | 1.56 | 69 | null | 2016-06-21 | 2016-06-21 | Y-90 | N | null | BEAM | 100945472 |
| 70049594 | 70143066 | 1.99 | 18.2 | Curative (C) | 2017-03-29 | 2017-04-28 | Y-90 | 02 | N | GDP R | 101196705 |
| 70066341 | 70143369 | 1.8 | 103.8 | null | 2020-01-08 | 2020-01-11 | Y-90 | N | null | NORDIC | 101106174 |
| 70067919 | 70143383 | null | 18.7 | Curative (C) | 2018-03-06 | 2018-04-14 | Y-90 | N | N | FLUOROURACIL | 100425507 |
| 70047429 | 70162742 | 1.99 | 75.6 | null | 2019-10-16 | 2019-11-14 | Y-90 | 02 | null | MOGAMULIZUMAB | 100543397 |
| 70050484 | 70162792 | 0 | 26.4 | Curative (C) | 2019-02-01 | 2019-02-02 | Y-90 | 2 | null | ALL INT GDE 2019 DEL INT B | 100652437 |
| 20220479 | 20088793 | 1.81 | 65 | Palliative (P) | 2017-08-13 | 2017-08-13 | Y-90 | 01 | N | RITUXIMAB | 100467656 |
| 70056512 | 70202987 | null | null | Curative (C) | 2021-09-28 | 2022-05-29 | Y-90 | 02 | N | ALCL ALCL 99 CLOSED PRE PHASE | 100277005 |
| 70038896 | 70067868 | 0 | 21.8 | Curative (C) | 2019-10-07 | 2019-11-05 | Y-90 | 02 | N | DHAP | 100399377 |
| 70098498 | 70069747 | null | null | null | 2019-03-21 | 2019-03-29 | Y-90 | 02 | N | DAUNORUBICIN | 101296600 |
| 70057708 | 70113778 | 0.99 | 82.2 | Curative (C) | 2020-01-31 | 2020-02-21 | Y-90 | 02 | N | ALL INT GDE 2019 NOPHO B | 101658552 |
| 70058850 | 70113809 | 1.8 | 61.8 | Curative (C) | 2019-01-27 | 2020-04-24 | Y-90 | N | N | CRIZOTINIB | 100339080 |
| 70060850 | 70113844 | 0.96 | 20.5 | null | 2018-10-31 | 2018-10-31 | Y-90 | 99 | null | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 100005947 |
| 70065635 | 70113893 | 1.66 | 71.7 | null | 2017-10-03 | 2017-10-07 | Y-90 | 01 | null | BENDAMUSTINE + GEMCITABINE + VINORELBINE | 100895831 |
| 70066131 | 70113899 | 0 | 77.7 | Disease modification (D) | 2018-09-22 | 2018-09-22 | Y-90 | 02 | N | TRANSPLANT ALEMTUZUMAB | 100958648 |
| 70069665 | 70113947 | 1.65 | 90 | Palliative (P) | 2016-09-06 | 2016-10-21 | Y-90 | 01 | N | IBRUTINIB + RITUXIMAB | 100461949 |
| 70070029 | 70190947 | 0 | 104 | Curative (C) | 2019-05-24 | 2019-05-25 | Y-90 | 02 | null | FLUOROURACIL + OXALIPLATIN | 101465596 |
| 80055374 | 80050086 | 0 | 27.5 | null | 2021-07-08 | 2021-08-13 | WT2001 | null | null | DACTINOMYCIN + VINCRISTINE | 101445200 |
| 80070582 | 80050250 | 1.67 | 17.5 | null | 2018-10-24 | 2018-12-07 | WT relapse Irinotecan/ Temozolamide/ Vincristine | null | null | BORTEZOMIB + THALIDOMIDE | 100411468 |